Official recall notice

FDA DrugN/A

FDA Recall: Vitruvias Therapeutics: Thyroid Tablets, USP 30 mg

Recall date
2026-08-24
Category
Drug

Why it was recalled

Hazard

Potential for the Product to be Superpotent

Product description

Potential for the Product to be Superpotent

Verify with the official notice →
Share:

Related Recalls

2026-08-26 · FDA_DRUG
FDA Recall: Baxter: 0.9% Sodium Chloride Injection, USP, 500 mL VIAFLEX Plastic Container
Baxter
2026-08-25 · FDA_DRUG
FDA Recall: Baxter: 70% Dextrose Injection, USP in 2000 mL VIAFLEX Plastic Container
Baxter
2026-08-25 · FDA_DRUG
FDA Recall: Baxter: Anticoagulant Sodium Citrate Solution USP, 250 mL VIAFLEX Plastic Container
Baxter
2026-08-20 · FDA_DRUG
FDA Recall: Optimal Balance Pharmacy: Glutathione Injection 200MG/ML (30ML), Multi-Dose Vial
Optimal Balance Pharmacy